- DESCRIPTION
- TABLE OF CONTENTS
- METHODOLOGY
- DOWNLOAD PDF
Remote Patient Monitoring (RPM) Market by Offering [Software, Device (Wearable, Implants, Handheld)], Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End User (Hospital, ASC, Pharma & Biotech) - Global Forecast to 2031
USD 66.33 BN
MARKET SIZE, 2031
REMOTE PATIENT MONITORING MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global remote patient monitoring market is projected to grow from USD 36.29 billion in 2026 to USD 66.23 billion by 2031, at a CAGR of 12.8% during the forecast period. The market was valued at USD 31.81 billion in 2025. The development of the remote patient monitoring (RPM) market is fueled by the digitization of healthcare delivery, the adoption of telemedicine in RPM, and the rising prevalence of chronic illness, especially among the aging population. Furthermore, favorable insurance coverage policies, smartphone adoption rates, cloud technology adoption in the healthcare sector, and innovations in artificial intelligence-based monitoring solutions are fueling RPM market growth.
KEY TAKEAWAYS
-
By Region
North America accounted for a 53.3% share of the global RPM market in 2025.
-
By Component
By component, the software segment is expected to register the highest CAGR of 14.8%.
-
By Indication
By indication, the cardiology segment accounted for the largest share of the global RPM market in 2024.
-
By End User
By end user, the patients segment is expected to register the highest CAGR of 13.4%.
-
Competitive Landscape
Koninklijke Philips N.V., OMRON Healthcare, Inc., and Medtronic were identified as some of the star players in the RPM market (global), given their strong market share and product footprint.
-
Competitive Landscape
Companies such as CareSimple Inc., TimeDoc, Inc., among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The remote patient monitoring (RPM) market is witnessing strong growth, which can be attributed to the digital revolution that has been taking place within the field of patient care, as well as the increasing prevalence of telehealth services along with the growing prevalence of chronic diseases among patients. Furthermore, the growth is also being propelled by the advancement in technology for wearables and mobile health applications.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
Consumer impact due to changing business in RPM has been brought about by emerging models of healthcare delivery, as well as increased disruption by digital technology. Hospitals, healthcare providers, payers, and home care providers are the leading users of RPM services in their quest to increase efficiency and improve patient outcomes. Changes in the healthcare landscape are evident in a shift toward a model of delivering continuous, data-driven home-based care to patients.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
OPPORTUNITIES
Impact
Level
-
Emergence of AI & ML
-
Gradual shift toward outpatient care environments
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The expansion of telehealth services across the globe is a driver for RPM by ensuring access to healthcare for patients anytime and anywhere. For instance, telehealth flexibility policies that include home-based supervision and behavioral health services through virtual supervision from CMS have contributed significantly to the adoption of RPM. CMS approved hospital-at-home programs that allowed 345 hospitals across 137 health systems to provide advanced medical care using telehealth. In India, more than 1,600 doctors used the telemedicine platform, Sanjeevani, to connect with over 40,000 patients daily.
The large initial costs involved in deploying RPM systems, along with the scarcity of IT specialists, are some of the primary barriers impeding market growth. In accordance with the HHS OCR data breach portal update issued in February 2026, based on data collected from 2025, network/server breaches made up 61.5% of all reportable breaches, while email compromises were found to account for 24.9%. The inadequately resourced IT landscape thus poses a serious threat to RPM deployment initiatives, while also affecting system integration and maintenance.
The advent of artificial intelligence (AI) and machine learning (ML) has brought an opportunity for the remote patient monitoring (RPM) market. With the use of such technologies, one can predict and detect health problems and come up with treatment plans based on real-time patient data. In January 2026, Lord's Mark Industries launched contactless remote patient monitoring (RPM) software, which was implemented at Gauhati Medical College & Hospital in India. It uses artificial intelligence analytics and camera-based monitoring for real-time patient tracking. This demonstrates the growing usage of AI and ML in RPM technology solutions.
Issues related to data security create a challenge to the development of the remote patient monitoring market. The constant flow of data in the form of sensitive health information through interconnected systems creates potential risks of cyber threats, data theft, and breaches. Complying with healthcare data privacy and protection standards, such as HIPAA and GDPR, is yet another hurdle. Security challenges can hinder adoption by affecting patient trust and making healthcare institutions reluctant to implement RPM technologies.
REMOTE PATIENT MONITORING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Virtual Care Management and connected monitoring for chronic conditions (diabetes, COPD, heart disease) | Reduces hospital readmissions, improves outcomes and patient engagement, lowers care costs |
|
|
VitalSight home blood pressure and weight monitoring linked to clinicians | Enables early intervention, better hypertension control, and continuous patient oversight |
|
|
MyCareLink Smart and Vital Sync for remote monitoring of implantable and hospital-to-home patients | Early detection of complications, reduced hospital stay and improved chronic care management |
|
|
Deployment of RPM/virtual-care solutions by combining GE’s inpatient/acute monitoring portfolio with home-based virtual-care and remote-monitoring | Extends hospital-grade monitoring to home, improves capacity, and reduces readmissions |
|
|
CardioMEMS HF System for remote monitoring of heart-failure patients | Cuts hospitalizations and mortality, enables proactive treatment, and enhances quality of life |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The remote patient monitoring market's ecosystem comprises entities responsible for the end-to-end workflow of RPM services. The significant stakeholders in this market include telecommunications companies (i.e., network, connectivity, and hardware providers); CT tools and electronics manufacturers (i.e., infrastructure service providers); and service & medical device providers. Healthcare providers (hospitals, health systems, physicians, ACSs, and clinics), Payers, patients/customers, health retailers, senior living/post-acute/hospice centers, start-ups, and governments and regulatory bodies are also stakeholders of this market. Solution and service providers continue to enhance and mature their offerings to increase the value addition. Various hospitals across the world are availing RPM solutions to improve care delivery.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
In 2025, the device segment held the largest share of the remote patient monitoring (RPM) market. This leadership is driven by the extensive use of sensors, vital signs monitors, implantable medical devices, and connected medical devices that facilitate real-time data collection and monitoring. The devices include the FreeStyle Libre CGM from Abbott, the Dexcom G7, the LINQ II insertable cardiac monitor from Medtronic, the Lux-Dx cardiac monitor from Boston Scientific, the Biosensor BX100 wearable monitor by Philips, and the OMRON connected blood pressure monitors. These devices provide continuous real-time patient monitoring, remote clinician access, and alerts, making them key players in the RPM market.
In 2025, cardiology accounted for the largest share of the remote patient monitoring (RPM) market. The American Heart Association estimates that more than 130 million Americans are predicted to develop any kind of cardiovascular disease by 2035. RPM in the field of cardiology has gained even more momentum owing to the increased use of smart ECG devices, implantable cardiac monitors, cardiac telemonitoring devices, remote monitoring devices for pacemakers, and heart failure management devices. There have also been new product launches, which have further bolstered the market. For example, Boston Scientific has introduced a new LUX-Dx II+ Insertable Cardiac Monitor System in 2025.
In 2025, healthcare providers held the largest share of the remote patient monitoring (RPM) market. This is attributed to increased adoption of RPM systems within healthcare facilities to increase patient satisfaction and ensure compliance with the treatment regimen. Connected monitoring systems are increasingly adopted by hospitals, clinics, and home health providers in the management of chronic diseases and monitoring patients who have been discharged. Increased uptake of home hospital services, value-based care systems, favorable reimbursement systems, and the use of telehealth have increased the need for RPM systems. The Centers for Disease Control and Prevention estimates that about 6 out of 10 adults in the US have at least one chronic condition, creating substantial demand for continuous patient monitoring solutions.
REGION
Asia Pacific to be fastest-growing region in global RPM market during forecast period
The Asia Pacific remote patient monitoring (RPM) market is expected to register the highest CAGR during the forecast period, due to the increasing digitization of healthcare, the high prevalence of chronic diseases among patients, and government interventions to encourage telehealth services. Some of the key countries with increasing adoption of connected health devices and applications include China, India, Japan, and South Korea. For example, Abbott disclosed that the FreeStyle Libre CGM system is being used by 8 million patients globally, and some of those regions are the Asia Pacific regions including India, China, Japan, and Australia. ABDM (Ayushman Bharat Digital Mission), launched by the government of India, is helping in growing the adoption of digital health services and connected patient data management. As of February 2025, more than 73.98 crore ABHA (Ayushman Bharat Health Account) ID numbers have been generated. Such initiatives highlight the growth of RPM in Asia-Pacific markets.
REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX
In the Remote Patient Monitoring (RPM) market matrix, Abbott (Star) is the leading competitor because of its large market share and wide variety of products, due to its high-performance health connectivity technology, like glucose monitors, cardiac rhythm management systems, and wearables. On the other hand, Teladoc Health Inc. (Emerging Leader) is emerging as a leader in RPM with its growing virtual healthcare network through RPM solutions and telemedicine platforms.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Koninklijke Philips N.V. (Netherlands)
- OMRON Healthcare, Inc. (Japan)
- Medtronic (Ireland)
- GE Healthcare (US)
- Abbott (US)
- Oracle (US)
- Boston Scientific Corporation (US)
- NIHON KOHDEN CORPORATION (Japan)
- Siemens Healthineers AG (Germany)
- Baxter (US)
- Biobeat (Israel)
- Biotronik (Germany)
- VitalConnect (US)
- VivaLNK, Inc (US)
- Clear Arch, Inc (US)
- Optum, Inc (Vivifyhealth) (US)
- Blue Spark Technologies, Inc (US)
- Lightbeam (US)
- Cloud Diagnostics Canada ULC (Canada)
- Teladoc Health, Inc (US)
- Guangdong Transtek Medical Electronics Co., Ltd (China)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) (Base Year) | USD 31.81 Billion |
| Market Size in 2026 (Value) (Estimated Year) | USD 36.29 Billion |
| Market Forecast in 2031 (Value) (Forecast Year) | USD 66.33 Billion |
| CAGR | CAGR of 12.8% from 2026-2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | USD Billion |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Asia Pacific, Europe, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: REMOTE PATIENT MONITORING MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Healthcare Provider | Adoption benchmarking of RPM platforms across hospitals and clinics, Integration analysis with existing EHR and telehealth systems | Optimize clinical workflows and patient engagement strategies, Identify operational efficiencies and cost savings from remote care |
| Device Manufacturer | Competitive assessment of RPM device portfolios (wearables, biosensors, implantables), Technology roadmap for connectivity, AI, and interoperability | Detect product innovation gaps, Highlight opportunities for strategic partnerships with health systems |
| Payer & Insurance Company | Cost-benefit modeling of RPM-enabled care programs, Evaluation of reimbursement trends and payer adoption policies | Identify high-value disease management opportunities, Strengthen policy frameworks for RPM reimbursement |
| Software / Platform Developer | Evaluation of API integration and interoperability across RPM ecosystems, Market mapping of AI-driven analytics platforms | Pinpoint innovation opportunities in predictive analytics, Strengthen differentiation through secure, interoperable architectures |
| Government / Public Health Agency | Assessment of RPM adoption in national telehealth initiatives, Policy mapping for remote care reimbursement frameworks | Support digital health policy development, Identify infrastructure gaps in rural or underserved regions |
| Home Healthcare Service Provider | Operational analysis for scaling home-based RPM programs, Mapping of vendor partnerships for device deployment and support | Enhance quality-of-care delivery in home settings, Strengthen partnerships with payers and hospitals |
RECENT DEVELOPMENTS
- February 2026 : Biotronik partnered with MiCare Path to deliver a comprehensive remote physiologic monitoring (RPM) program for cardiology practices, combining BIOMONITOR IV insertable cardiac monitor devices with MiCare Path RPM devices.
- June 2025 : Philips expanded collaboration efforts for connected patient monitoring through integrated monitoring and consumable solutions with Medtronic, aiming to streamline hospital monitoring workflows and improve RPM-enabled clinical decision-making.
- April 2025 : Medtronic advanced its collaboration with Abbott through the FDA submission of an interoperable insulin pump designed to integrate with Abbott’s advanced CGM platform.
- COLUMN 'A' SHOULD BE IN TEXT FORMAT AND NOT DATE FORMAT :
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
4
MARKET OVERVIEW
49
4.1.1.1
TRANSFORMATION OF PATIENT CARE THROUGH DIGITAL INNOVATION
4.1.1.2
EXPANSION OF TELEHEALTH IN REMOTE PATIENT MONITORING
4.1.1.3
RISING PREVALENCE OF CHRONIC DISEASES
4.1.1.4
INCREASING GERIATRIC POPULATION AND RISING UPTAKE OF RPM SERVICES
4.1.1.5
GROWING NEED FOR COST-CONTAINMENT ACROSS HEALTHCARE FACILITIES
4.1.1.6
TECHNOLOGICAL INNOVATION IN WEARABLES, MHEALTH APPS, AND CONNECTED DEVICES
4.1.2.1
HIGH INVESTMENTS AND LACK OF IT EXPERTISE
4.1.2.2
BEHAVIORAL BARRIERS AND HEALTHCARE AFFORDABILITY CHALLENGES IN REMOTE PATIENT MONITORING
4.1.2.3
CHALLENGES ASSOCIATED WITH CMS REGULATIONS
4.1.3.1
EMERGENCE OF AI & ML
4.1.3.2
GRADUAL SHIFT TOWARD OUTPATIENT CARE ENVIRONMENTS
4.1.3.3
INCREASING UTILIZATION FOR INFECTIOUS DISEASE DIAGNOSTICS
4.1.3.4
RISING INITIATIVES FOR HOSPITAL-AT-HOME PROGRAMS
4.1.4.1
CONCERNS ASSOCIATED WITH DATA SECURITY
4.1.4.2
DATA ACCESSIBILITY ISSUES
4.1.4.3
INCORPORATION OF SDOH FACTORS INTO RPM PROGRAMS
4.2
UNMET NEEDS AND WHITE SPACES
4.3
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4
STRATEGIC MOVES BY TIER 1/2/3
5
INDUSTRY TRENDS
66
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
THREAT OF SUBSTITUTES
5.1.3
BARGAINING POWER OF SUPPLIERS
5.1.4
BARGAINING POWER OF BUYERS
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.1.6
GRADUAL SHIFT TO VALUE-BASED & PATIENT-CENTRIC CARE
5.2
MACROECONOMIC INDICATORS
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN GLOBAL HEALTHCARE
5.5.1
INDICATIVE PRICING FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2025)
5.5.2
INDICATIVE PRICE FOR REMOTE PATIENT MONITORING BY REGION (2025)
5.6
TARIFF & REGULATORY ANALYSIS
5.6.1
TARIFF DATA (HS CODE 9018)
5.6.2
TARIFF DATA (HS CODE 9021)
5.6.3
TARIFF DATA (HS CODE 9022)
5.7.1
TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 90189099)
5.7.2
TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 9021)
5.7.3
TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES (HSN CODE: 9022)
5.8
KEY CONFERENCES AND EVENTS, 2026−2027
5.8.1
REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10.1
REMOTE PATIENT MONITORING PORTAL AUTOMATION
5.10.1.1
CASE 1: COST SAVINGS AND PERFORMANCE BOOST THROUGH AUTOMATION
5.10.2
PATIENT MONITORING PORTAL AUTOMATION
5.10.2.1
CASE 2: RPM DRIVES ENGAGEMENT AND GENERATES SUBSTANTIAL RETURNS
5.11
IMPACT OF 2025 US TARIFF – REMOTE PATIENT MONITORING MARKET
5.11.3
PRICE IMPACT ANALYSIS
5.11.4
IMPACT ON COUNTRY/REGION
5.11.5
IMPACT ON END USERS
5.11.5.1
HEALTHCARE PROVIDERS
5.11.5.2
HEALTHCARE PAYERS
5.11.5.4
PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES
5.11.5.5
MEDTECH COMPANIES
5.12.1
KEY EMERGING TECHNOLOGIES
5.12.1.1
MINIATURE WEARABLE DEVICES
5.12.1.2
ARTIFICIAL INTELLIGENCE & MACHINE LEARNING
5.12.1.4
PATIENT ENGAGEMENT TOOLS
5.12.1.6
VOICE ASSISTANT INTEGRATION
5.12.2
COMPLEMENTARY TECHNOLOGIES
5.12.2.3
DIGITAL THERAPEUTICS
5.12.2.4
TELEHEALTH PLATFORMS
5.12.3
ADJACENT TECHNOLOGIES
5.12.3.2
SMART HOME HEALTH DEVICES
5.13
TECHNOLOGY/PRODUCT ROADMAP
5.14.1
PATENT PUBLICATION TRENDS FOR REMOTE PATIENT MONITORING
5.14.2
JURISDICTION AND TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING
5.14.3
LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET
5.16
IMPACT OF GENERATIVE AI/AI ON REMOTE PATIENT MONITORING MARKET
5.16.2
CASE STUDIES FOR GENERATIVE AI/AI IMPLEMENTATION
5.16.2.1
CASE STUDY 1: ENHANCING REMOTE PATIENT MONITORING FOR CANCER TREATMENT WITH NLP AND HIPAA-COMPLIANT ANNOTATION
5.16.2.2
CASE STUDY 2: LEVERAGING AI FOR PROACTIVE INFECTION PREVENTION IN HOSPITALS
5.16.2.3
TELEHEALTH & TELEMEDICINE
5.16.2.4
WEARABLE DEVICES
5.16.2.5
DIGITAL HEALTHCARE
5.16.3
USER READINESS & IMPACT ASSESSMENT
5.16.3.1.1
USER A: HOSPITALS
5.16.3.1.2
USER B: AMBULATORY SURGERY CENTERS
5.16.3.2
IMPACT ASSESSMENT
5.16.3.2.1
USER A: HOSPITALS
5.16.3.2.2
USER B: AMBULATORY SURGERY CENTERS
5.16.4
REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
5.16.5
REGULATORY ANALYSIS
6
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
107
6.2
DECISION-MAKING PROCESS
6.3
KEY STAKEHOLDERS AND BUYING CRITERIA
6.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
6.4.2
END USER EXPECTATIONS
6.5
ADOPTION BARRIERS & INTERNAL CHALLENGES
7
REMOTE PATIENT MONITORING MARKET, BY COMPONENT
112
7.2.1.1
CARDIAC MONITORING DEVICES
7.2.1.1.1
INCREASING UPTAKE OF ECG MONITORS AND RISING CASES OF HYPERTENSION TO FUEL MARKET
7.2.1.2
NEUROLOGICAL MONITORING DEVICES
7.2.1.2.1
GROWING DEMAND FOR CLINICAL-GRADE WEARABLE DEVICES FOR ROUTINE MONITORING TO DRIVE MARKET
7.2.1.3
RESPIRATORY MONITORING DEVICES
7.2.1.3.1
RISING DEMAND FOR PEAK FLOW METERS AND SLEEP APNEA MONITORS TO FUEL MARKET
7.2.1.4
BLOOD GLUCOSE MONITORING DEVICES
7.2.1.4.1
INCREASING PREVALENCE OF DIABETES TO SUPPORT MARKET GROWTH
7.2.1.5
FETAL & NEONATAL MONITORING DEVICES
7.2.1.5.1
GROWING FOCUS ON VITAL HEALTH MONITORING IN PRETERM BIRTHS TO DRIVE MARKET
7.2.1.6
WEIGHT MONITORING DEVICES
7.2.1.6.1
HIGH INCIDENCE OF OBESITY AND GROWING ADVANCEMENTS IN SMART WEIGHING SCALES TO FUEL MARKET
7.2.1.7
MULTIPARAMETER MONITORING DEVICES
7.2.1.7.1
MEASUREMENT OF SPO2, BLOOD SUGAR, AND RESPIRATORY ACTIVITY TO FUEL UPTAKE
7.2.1.8
PULSE OXIMETER DEVICES
7.2.1.8.1
RISING DEMAND IN PREOPERATIVE & HOME CARE SETTINGS TO SUPPORT MARKET GROWTH
7.2.1.9.1
GROWING FOCUS ON HOME HEALTHCARE TO FUEL MARKET
7.2.1.10
OTHER MONITORING DEVICES
7.2.2.1.1
ABILITY TO PROVIDE REAL-TIME INSIGHTS TO DRIVE MARKET
7.2.2.2
IMPLANTABLE DEVICES
7.2.2.2.1
ADVANCEMENTS IN WIRELESS COMMUNICATION TECHNOLOGIES TO BOOST DEMAND
7.2.2.3
HANDHELD & PORTABLE DEVICES
7.2.2.3.1
GROWING FOCUS ON DEVICE MINIATURIZATION TO FUEL MARKET
7.3.1
SOFTWARE, BY DEPLOYMENT MODEL
7.3.1.1.1
ENHANCED CONTROL, DATA SECURITY, AND CUSTOMIZATION BENEFITS TO FUEL MARKET
7.3.1.2
CLOUD-BASED MODELS
7.3.1.2.1
REAL-TIME DATA SHARING AND HIGH-SECURITY FEATURES TO BOOST DEMAND
7.3.2
SOFTWARE, BY TRANSMISSION TYPE
7.3.2.1
SYNCHRONOUS TRANSMISSION
7.3.2.1.1
GROWING AVAILABILITY OF REAL-TIME DATA ANALYTICS TO BOOST DEMAND
7.3.2.2
ASYNCHRONOUS TRANSMISSION
7.3.2.2.1
INCREASING NEED FOR LOW-RESOURCE FLEXIBLE SOLUTIONS TO SUPPORT MARKET GROWTH
7.4.1
EXPANSION OF TELEMEDICINE PLATFORMS AND INTEGRATION OF SERVICE MODELS TO SUPPORT MARKET GROWTH
8
REMOTE PATIENT MONITORING MARKET, BY INDICATION
135
8.2.1
GROWING FOCUS ON EARLY DISEASE DETECTION TO DRIVE MARKET
8.3.1
HIGH INCIDENCE OF CVD TO PROPEL MARKET
8.4.1
INCREASING PREVALENCE OF NEUROLOGICAL CONDITIONS TO FUEL MARKET
8.5.1
GROWING FOCUS ON TELEHEALTH CONSULTATIONS FOR DIABETES MANAGEMENT TO BOOST DEMAND
8.6.1
INCREASING INCIDENCE OF SLEEP APNEA TO SUPPORT MARKET GROWTH
8.7.1
RISING CASES OF COPD AND ASTHMA TO FUEL MARKET
8.8.1
UTILIZATION OF WEIGHT MANAGEMENT & PERSONAL HEALTH APPS TO SUPPORT MARKET GROWTH
8.9.1
GROWING FOCUS ON DEVELOPMENT OF PREDICTIVE HEALTH MODELS FOR COGNITIVE THERAPY TO PROPEL MARKET
9
REMOTE PATIENT MONITORING MARKET, BY END USER
146
9.2.1.1
ABILITY TO PURCHASE TECHNOLOGICALLY ADVANCED TELEHEALTH DEVICES TO FUEL MARKET
9.2.2
ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS
9.2.2.1
INCREASING DEMAND FOR COST-EFFECTIVE PERIOPERATIVE DEVICES TO FUEL MARKET
9.2.3
LONG-TERM CARE & ASSISTED LIVING FACILITIES
9.2.3.1
EXPANDING GERIATRIC POPULATION AND GROWING FOCUS ON CHRONIC DISEASE MANAGEMENT TO FUEL MARKET
9.2.4.1
GROWING PREFERENCE FOR REMOTE CARE TO DRIVE MARKET
9.2.5
OTHER HEALTHCARE PROVIDERS
9.3.1
LOW COSTS AND IMPROVED HEALTHCARE FACILITIES TO DRIVE MARKET
9.4.1
INCREASING FOCUS ON AI INTEGRATION INTO WEARABLE DEVICES TO BOOST DEMAND
9.5
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.5.1
RISING NEED FOR ENHANCED CLINICAL TRIAL OUTCOMES TO SUPPORT MARKET GROWTH
9.6.1
INTEGRATION OF RPM WITH MEDTECH SOLUTIONS FOR DIAGNOSTIC ACCURACY TO FUEL MARKET
10
REMOTE PATIENT MONITORING MARKET, BY REGION
158
10.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2.1
SUPPORTIVE REGULATORY FRAMEWORKS FOR AI IMPLEMENTATION TO BOOST DEMAND
10.2.3.1
GROWING NEED TO CURTAIL HEALTHCARE COSTS TO DRIVE MARKET
10.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2.1
FAVORABLE REIMBURSEMENTS FOR TECHNOLOGICAL INNOVATION TO PROPEL MARKET
10.3.3.1
GOVERNMENT SUPPORT FOR AI IMPLEMENTATION TO BOOST DEMAND
10.3.4.1
IMPLEMENTATION OF ETAPES PROGRAM TO FUEL MARKET
10.3.5.1
GROWING FOCUS ON DIGITAL TRANSFORMATION FOR VALUE-CENTRIC PATIENT CARE TO DRIVE MARKET
10.3.6.1
RISING FUNDING INVESTMENTS FOR DIGITAL HEALTH PLANS TO BOOST MARKET
10.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2.1
SHORTAGE OF PHYSICIANS AND GROWING FOCUS ON RPM SOLUTIONS TO SUPPORT MARKET GROWTH
10.4.3.1
RISING GERIATRIC POPULATION AND SUBSEQUENT RISE IN PREVENTIVE CARE TO DRIVE MARKET
10.4.4.1
EXPANDING TARGET PATIENT POPULATION TO DRIVE MARKET
10.4.5.1
GROWING GOVERNMENT SUPPORT AND TELEHEALTH EXPANSION TO DRIVE MARKET
10.4.6.1
STRATEGIC PARTNERSHIPS AND AI INNOVATIONS ACCELERATE RPM ADOPTION
10.4.7
REST OF ASIA PACIFIC
10.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2.1
GROWING FOCUS ON TELEHEALTH CONSULTATIONS TO DRIVE MARKET
10.5.3.1
IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO BOOST DEMAND
10.5.4
REST OF LATIN AMERICA
10.6
MIDDLE EAST & AFRICA
10.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2.1
GOVERNMENT INITIATIVES FOR INVESTMENTS IN RPM SOLUTIONS TO SUPPORT MARKET GROWTH
10.6.3.1
EXPANSION OF CONNECTED HEALTHCARE ECOSYSTEM
10.6.4.1
STRENGTHENING OF CONNECTED HEALTHCARE ECOSYSTEM WITH AI-ENABLED RPM SOLUTIONS TO BOOST MARKET
10.6.5.1
MARKET PROPELLED BY DIGITAL HEALTH TRANSFORMATION
10.6.6.1
INCREASING ADOPTION OF TELEHEALTH INFRASTRUCTURE TO DRIVE MARKET
10.6.7
REST OF MIDDLE EAST & AFRICA
11
COMPETITIVE LANDSCAPE
273
11.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET
11.3
REVENUE ANALYSIS, 2021–2025
11.4
MARKET SHARE ANALYSIS, 2025
11.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
11.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
11.5.5.1
COMPANY FOOTPRINT
11.5.5.2
REGION FOOTPRINT
11.5.5.3
COMPONENT FOOTPRINT
11.5.5.4
INDICATION FOOTPRINT
11.5.5.5
END USER FOOTPRINT
11.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
11.6.1
PROGRESSIVE COMPANIES
11.6.2
RESPONSIVE COMPANIES
11.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
11.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
11.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
11.7
COMPANY VALUATION & FINANCIAL METRICS
11.8
BRAND/SOFTWARE COMPARISON
11.9
COMPETITIVE SCENARIO
11.9.1
PRODUCT/SERVICE LAUNCHES & APPROVALS
11.9.4
OTHER DEVELOPMENTS
12
COMPANY PROFILES
294
12.1.1
KONINKLIJKE PHILIPS N.V.
12.1.1.1
BUSINESS OVERVIEW
12.1.1.2
PRODUCTS/SERVICES OFFERED
12.1.1.3
RECENT DEVELOPMENTS
12.1.1.3.1
PRODUCT/SERVICE LAUNCHES & APPROVALS
12.1.1.4.2
STRATEGIC CHOICES
12.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
12.1.2
OMRON HEALTHCARE, INC. (SUBSIDIARY OF OMRON CORPORATION)
12.1.7
BOSTON SCIENTIFIC CORPORATION
12.1.8
NIHON KOHDEN CORPORATION
12.1.9
SIEMENS HEALTHINEERS AG
12.1.16
OPTUM, INC. (VIVIFY HEALTH – PART OF OPTUM)
12.1.17
BLUE SPARK TECHNOLOGIES, INC.
12.1.19
CLOUD DIAGNOSTICS CANADA ULC
12.1.20
TELADOC HEALTH, INC.
12.1.21
GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.
12.2.4
DOZEE (TURTLE SHELL TECHNOLOGIES PVT LTD)
12.2.5
HEALTH RECOVERY SOLUTIONS
13
RESEARCH METHODOLOGY
367
13.1.1.1
KEY DATA FROM SECONDARY SOURCES
13.1.2.1
KEY DATA FROM PRIMARY SOURCES
13.1.2.2
BREAKDOWN OF PRIMARY SOURCES
13.2
MARKET SIZE ESTIMATION
13.2.1
SUPPLY-SIDE ANALYSIS
13.2.2
BOTTOM-UP APPROACH: END USER ADOPTION
13.2.3
TOP-DOWN OF PARENT MARKET ASSESSMENT
13.2.4
COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
13.3
MARKET BREAKDOWN AND DATA TRIANGULATION
13.4
RESEARCH ASSUMPTIONS
13.4.1
MARKET SIZING ASSUMPTIONS
13.4.2
OVERALL STUDY ASSUMPTIONS
13.6
RESEARCH LIMITATIONS
13.6.1
METHODOLOGY-RELATED LIMITATIONS
13.6.2
SCOPE-RELATED LIMITATIONS
14.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3
CUSTOMIZATION OPTIONS
TABLE 1
USD EXCHANGE RATES
TABLE 2
RECENT DEVELOPMENTS OF AI IN REMOTE PATIENT MONITORING MARKET, JANUARY 2022–DECEMBER 2024
TABLE 3
TOP FIVE HEALTHCARE ORGANIZATIONS IMPACTED BY SECURITY BREACHES
TABLE 4
REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 5
INDICATIVE PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER (2025)
TABLE 6
INDICATIVE PRICE OF REMOTE PATIENT MONITORING DEVICES, BY REGION, 2025 (USD)
TABLE 7
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 8
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING
TABLE 9
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
NORTH AMERICA: REGULATORY ANALYSIS
TABLE 15
EUROPE: REGULATORY ANALYSIS
TABLE 16
ASIA PACIFIC: REGULATORY ANALYSIS
TABLE 17
MIDDLE EAST & AFRICA: REGULATORY ANALYSIS
TABLE 18
LATIN AMERICA: REGULATORY ANALYSIS
TABLE 19
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING, BY END USER
TABLE 20
KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING
TABLE 21
UNMET NEEDS IN REMOTE PATIENT MONITORING MARKET
TABLE 22
END USER EXPECTATIONS IN REMOTE PATIENT MONITORING MARKET
TABLE 23
REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 24
REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 25
REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 26
CARDIAC MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 27
NEUROLOGICAL MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 28
RESPIRATORY MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 29
BLOOD GLUCOSE MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 30
FETAL & NEONATAL MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 31
WEIGHT MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 32
MULTIPARAMETER MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 33
PULSE OXIMETER DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 34
THERMOMETERS: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 35
OTHER MONITORING DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 36
REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 37
WEARABLE DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 38
IMPLANTABLE DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 39
HANDHELD & PORTABLE DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 40
OTHER DEVICES: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 41
REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY REGION, 2024–2031 (USD MILLION)
TABLE 42
REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 43
ON-PREMISE MODELS: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 44
CLOUD-BASED MODELS: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 45
REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 46
SYNCHRONOUS TRANSMISSION: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 47
ASYNCHRONOUS TRANSMISSION: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 48
REMOTE PATIENT MONITORING MARKET FOR SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 49
REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 50
REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION, 2024–2031 (USD MILLION)
TABLE 51
REMOTE PATIENT MONITORING MARKET FOR CARDIOLOGY, BY REGION, 2024–2031 (USD MILLION)
TABLE 52
REMOTE PATIENT MONITORING MARKET FOR NEUROLOGY, BY REGION, 2024–2031 (USD MILLION)
TABLE 53
REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION, 2024–2031 (USD MILLION)
TABLE 54
REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 55
REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY DISEASES, BY REGION, 2024–2031 (USD MILLION)
TABLE 56
REMOTE PATIENT MONITORING MARKET FOR WELLNESS IMPROVEMENT, BY REGION, 2024–2031 (USD MILLION)
TABLE 57
REMOTE PATIENT MONITORING MARKET FOR MENTAL HEALTH, BY REGION, 2024–2031 (USD MILLION)
TABLE 58
REMOTE PATIENT MONITORING MARKET FOR OTHER INDICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 59
REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 60
REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 61
REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 62
REMOTE PATIENT MONITORING MARKET FOR HOSPITALS, BY REGION, 2024–2031 (USD MILLION)
TABLE 63
REMOTE PATIENT MONITORING MARKET FOR ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2024–2031 (USD MILLION)
TABLE 64
REMOTE PATIENT MONITORING MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 65
REMOTE PATIENT MONITORING MARKET FOR HOME HEALTHCARE, BY REGION, 2024–2031 (USD MILLION)
TABLE 66
REMOTE PATIENT MONITORING MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 67
REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PAYERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 68
REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 69
REMOTE PATIENT MONITORING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 70
REMOTE PATIENT MONITORING MARKET FOR MEDTECH COMPANIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 71
REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 72
REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 73
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 74
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 75
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 76
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 77
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 78
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 79
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 80
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 81
US: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 82
US: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 83
US: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 84
US: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 85
US: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE,
TABLE 86
US: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 87
US: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 88
US: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 89
CANADA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 90
CANADA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 91
CANADA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 92
CANADA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 93
CANADA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 94
CANADA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 95
CANADA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 96
CANADA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 97
EUROPE: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98
EUROPE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 99
EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 100
EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 101
EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 102
EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 103
EUROPE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 104
EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 105
EUROPE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 106
GERMANY: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 107
GERMANY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 108
GERMANY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 109
GERMANY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 110
GERMANY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 111
GERMANY: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 112
GERMANY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 113
GERMANY: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 114
UK: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 115
UK: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 116
UK: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 117
UK: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 118
UK: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 119
UK: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 120
UK: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 121
UK: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122
FRANCE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 123
FRANCE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 124
FRANCE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 125
FRANCE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 126
FRANCE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 127
FRANCE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 128
FRANCE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 129
FRANCE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 130
ITALY: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 131
ITALY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 132
ITALY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133
ITALY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 134
ITALY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 135
ITALY: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 136
ITALY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 137
ITALY: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 138
SPAIN: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 139
SPAIN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 140
SPAIN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 141
SPAIN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 142
SPAIN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 143
SPAIN: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 144
SPAIN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 145
SPAIN: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 147
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 148
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 149
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 150
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 151
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 152
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 153
REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 154
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 155
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 156
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 157
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 158
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 159
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 160
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 161
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 162
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 163
CHINA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 164
CHINA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 165
CHINA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 166
CHINA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 167
CHINA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 168
CHINA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 169
CHINA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 170
CHINA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 171
JAPAN: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 172
JAPAN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 173
JAPAN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 174
JAPAN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 175
JAPAN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 176
JAPAN: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 177
JAPAN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 178
JAPAN: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 179
INDIA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 180
INDIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 181
INDIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 182
INDIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 183
INDIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 184
INDIA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 185
INDIA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 186
INDIA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187
AUSTRALIA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 188
AUSTRALIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 189
AUSTRALIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 190
AUSTRALIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 191
AUSTRALIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 192
AUSTRALIA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 193
AUSTRALIA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 194
AUSTRALIA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195
SOUTH KOREA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 196
SOUTH KOREA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 197
SOUTH KOREA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198
SOUTH KOREA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 199
SOUTH KOREA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 200
SOUTH KOREA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 201
SOUTH KOREA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 202
SOUTH KOREA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 203
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 204
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 205
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 206
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 207
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 208
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 209
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 210
REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 212
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 213
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 214
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 215
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 216
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 217
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 218
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 219
LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 220
BRAZIL: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 221
BRAZIL: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 222
BRAZIL: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 223
BRAZIL: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 224
BRAZIL: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 225
BRAZIL: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 226
BRAZIL: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 227
BRAZIL: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 228
MEXICO: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 229
MEXICO: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 230
MEXICO: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231
MEXICO: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 232
MEXICO: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 233
MEXICO: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 234
MEXICO: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 235
MEXICO: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 236
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 237
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 238
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 239
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 240
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 241
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 242
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 243
REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 244
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 245
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 246
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 247
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 248
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 249
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 250
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 251
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 252
MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 253
GCC: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 254
GCC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 255
GCC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 256
GCC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 257
GCC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 258
GCC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 259
GCC: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 260
GCC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 261
GCC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 262
SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 263
SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 264
SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 265
SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 266
SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 267
SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 268
SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 269
SAUDI ARABIA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 270
UAE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 271
UAE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 272
UAE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 273
UAE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 274
UAE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 275
UAE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 276
UAE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 277
UAE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 278
REST OF GCC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 279
REST OF GCC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 280
REST OF GCC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 281
REST OF GCC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 282
REST OF GCC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 283
REST OF GCC: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 284
REST OF GCC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 285
REST OF GCC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 286
SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 287
SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 288
SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 289
SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 290
SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 291
SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 292
SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 293
SOUTH AFRICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 294
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
TABLE 295
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 296
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 297
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2024–2031 (USD MILLION)
TABLE 298
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2024–2031 (USD MILLION)
TABLE 299
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024–2031 (USD MILLION)
TABLE 300
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 301
REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 302
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, JANUARY 2023–APRIL 2026
TABLE 303
REMOTE PATIENT MONITORING MARKET: DEGREE OF COMPETITION
TABLE 304
REMOTE PATIENT MONITORING MARKET: REGION FOOTPRINT
TABLE 305
REMOTE PATIENT MONITORING MARKET: COMPONENT FOOTPRINT
TABLE 306
REMOTE PATIENT MONITORING MARKET: INDICATION FOOTPRINT
TABLE 307
REMOTE PATIENT MONITORING MARKET: END USER FOOTPRINT
TABLE 308
REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 309
REMOTE PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION
TABLE 310
REMOTE PATIENT MONITORING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023–APRIL 2026
TABLE 311
REMOTE PATIENT MONITORING MARKET: DEALS, JANUARY 2023–APRIL 2026
TABLE 312
REMOTE PATIENT MONITORING MARKET: EXPANSIONS, JANUARY 2023–APRIL 2026
TABLE 313
REMOTE PATIENT MONITORING MARKET: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026
TABLE 314
KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 315
KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES OFFERED
TABLE 316
KONINKLIJKE PHILIPS N.V.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 317
KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023−APRIL 2026
TABLE 318
OMRON CORPORATION: COMPANY OVERVIEW
TABLE 319
OMRON HEALTHCARE, INC.: PRODUCTS/SERVICES OFFERED
TABLE 320
OMRON HEALTHCARE, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 321
OMRON HEALTHCARE, INC.: DEALS, JANUARY 2023−APRIL 2026
TABLE 322
OMRON HEALTHCARE, INC.: OTHER DEVELOPMENTS, JANUARY 2023−APRIL 2026
TABLE 323
MEDTRONIC: COMPANY OVERVIEW
TABLE 324
MEDTRONIC: PRODUCTS/SERVICES OFFERED
TABLE 325
MEDTRONIC: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 326
MEDTRONIC: DEALS, JANUARY 2023−APRIL 2026
TABLE 327
MEDTRONIC: OTHER DEVELOPMENTS, JANUARY 2023−APRIL 2026
TABLE 328
GE HEALTHCARE: COMPANY OVERVIEW
TABLE 329
GE HEALTHCARE: PRODUCTS/SERVICES OFFERED
TABLE 330
GE HEALTHCARE: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 331
GE HEALTHCARE: DEALS, JANUARY 2023−APRIL 2026
TABLE 332
ABBOTT: COMPANY OVERVIEW
TABLE 333
ABBOTT: PRODUCTS/SERVICES OFFERED
TABLE 334
ABBOTT: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 335
ABBOTT: EXPANSIONS, JANUARY 2023−APRIL 2026
TABLE 336
ABBOTT: OTHER DEVELOPMENTS, JANUARY 2023−APRIL 2026
TABLE 337
ORACLE: COMPANY OVERVIEW
TABLE 338
ORACLE: PRODUCTS/SERVICES OFFERED
TABLE 339
ORACLE: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 340
ORACLE: DEALS, JANUARY 2023−APRIL 2026
TABLE 341
BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 342
BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 343
BOSTON SCIENTIFIC CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 344
BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2023−APRIL 2026
TABLE 345
BOSTON SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023−APRIL 2026
TABLE 346
NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
TABLE 347
NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 348
NIHON KOHDEN CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 349
NIHON KOHDEN CORPORATION: DEALS, JANUARY 2023−APRIL 2026
TABLE 350
SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 351
SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED
TABLE 352
SIEMENS HEALTHINEERS AG: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 353
SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023−APRIL 2026
TABLE 354
BAXTER: COMPANY OVERVIEW
TABLE 355
BAXTER: PRODUCTS/SERVICES OFFERED
TABLE 356
BAXTER: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 357
BAXTER: DEALS, JANUARY 2023−APRIL 2026
TABLE 358
BIOBEAT: COMPANY OVERVIEW
TABLE 359
BIOBEAT: PRODUCTS/SERVICES OFFERED
TABLE 360
BIOBEAT: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 361
BIOBEAT: DEALS, JANUARY 2023−APRIL 2026
TABLE 362
BIOTRONIK: COMPANY OVERVIEW
TABLE 363
BIOTRONIK: PRODUCTS/SERVICES OFFERED
TABLE 364
BIOTRONIK: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 365
BIOTRONIK: DEALS, JANUARY 2023−APRIL 2026
TABLE 366
VITALCONNECT: COMPANY OVERVIEW
TABLE 367
VITALCONNECT: PRODUCTS/SERVICES OFFERED
TABLE 368
VITALCONNECT: DEALS, JANUARY 2023−APRIL 2026
TABLE 369
VITALCONNECT: OTHER DEVELOPMENTS, JANUARY 2023−APRIL 2026
TABLE 370
VIVALNK, INC.: COMPANY OVERVIEW
TABLE 371
VIVALNK, INC.: PRODUCTS/SERVICES OFFERED
TABLE 372
VIVALNK, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 373
VIVALNK, INC.: DEALS, JANUARY 2023−APRIL 2026
TABLE 374
CLEARARCH, INC.: COMPANY OVERVIEW
TABLE 375
CLEARARCH, INC.: PRODUCTS/SERVICES OFFERED
TABLE 376
CLEARARCH, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 377
CLEARARCH, INC.: DEALS, JANUARY 2023−APRIL 2026
TABLE 378
OPTUM, INC.: COMPANY OVERVIEW
TABLE 379
OPTUM, INC.: PRODUCTS/SERVICES OFFERED
TABLE 380
BLUE SPARK TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 381
BLUE SPARK TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 382
BLUE SPARK TECHNOLOGIES, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 383
LIGHTBEAM: COMPANY OVERVIEW
TABLE 384
LIGHTBEAM: PRODUCTS/SERVICES OFFERED
TABLE 385
LIGHTBEAM: DEALS, JANUARY 2023−APRIL 2026
TABLE 386
CLOUD DIAGNOSTICS CANADA ULC: COMPANY OVERVIEW
TABLE 387
CLOUD DIAGNOSTICS CANADA ULC: PRODUCTS/SERVICES OFFERED
TABLE 388
CLOUD DIAGNOSTICS CANADA ULC: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 389
CLOUD DIAGNOSTICS CANADA ULC: DEALS, JANUARY 2023−APRIL 2026
TABLE 390
TELADOC HEALTH, INC.: COMPANY OVERVIEW
TABLE 391
TELADOC HEALTH, INC.: PRODUCTS/SERVICES OFFERED
TABLE 392
TELADOC HEALTH, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023−APRIL 2026
TABLE 393
TELADOC HEALTH, INC.: DEALS, JANUARY 2023−APRIL 2026
TABLE 394
GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
TABLE 395
GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: PRODUCTS/SERVICES OFFERED
TABLE 396
GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2023−APRIL 2026
TABLE 397
FACTOR ANALYSIS
TABLE 398
RISK ASSESSMENT: REMOTE PATIENT MONITORING MARKET
FIGURE 1
REMOTE PATIENT MONITORING MARKET SEGMENTATION
FIGURE 3
GLOBAL REMOTE PATIENT MONITORING MARKET, 2024–2031
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, 2022–2026
FIGURE 5
DISRUPTIONS INFLUENCING GROWTH OF REMOTE PATIENT MONITORING MARKET
FIGURE 6
HIGH-GROWTH SEGMENTS IN REMOTE PATIENT MONITORING MARKET, 2026–2031
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN REMOTE PATIENT MONITORING MARKET DURING FORECAST PERIOD
FIGURE 8
GROWING ADOPTION OF TELEHEALTH AND REMOTE CARE TO DRIVE MARKET
FIGURE 9
DEVICES ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025
FIGURE 10
CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 11
REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 12
US: MEDICARE-CERTIFIED ASCS, BY STATE (AS OF SEPTEMBER 2024)
FIGURE 13
HEALTHCARE SECURITY BREACHES OF 500 + RECORDS, 2009–2024
FIGURE 14
REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 15
REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS
FIGURE 16
REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS
FIGURE 17
IMPORT OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2025 (USD THOUSAND)
FIGURE 18
EXPORTS OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2025 (USD THOUSAND)
FIGURE 19
IMPORT OF PRODUCTS UNDER HSN CODE: 9021, BY COUNTRY, 2025 (USD THOUSAND)
FIGURE 20
EXPORTS OF PRODUCTS UNDER HSN CODE: 9021, BY COUNTRY, 2025 (USD THOUSAND)
FIGURE 21
IMPORT OF PRODUCTS UNDER HSN CODE: 9022, BY COUNTRY, 2025 (USD THOUSAND)
FIGURE 22
EXPORTS OF PRODUCTS UNDER HSN CODE: 9022, BY COUNTRY, 2025 (USD THOUSAND)
FIGURE 23
JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING PATENTS (JANUARY 2015–DECEMBER 2025)
FIGURE 24
LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET (JANUARY 2015–DECEMBER 2025)
FIGURE 25
POTENTIAL OF GENERATIVE AI/AI IN REMOTE PATIENT MONITORING ACROSS INDUSTRIES
FIGURE 26
IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS
FIGURE 27
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING, BY END USER
FIGURE 28
KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING, BY COMPONENT
FIGURE 29
NORTH AMERICA: REMOTE PATIENT MONITORING MARKET SNAPSHOT
FIGURE 30
ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET SNAPSHOT
FIGURE 31
REVENUE ANALYSIS OF KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, 2021–2025 (USD MILLION)
FIGURE 32
REMOTE PATIENT MONITORING MARKET SHARE ANALYSIS OF KEY PLAYERS IN (2025)
FIGURE 33
REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 34
REMOTE PATIENT MONITORING MARKET: COMPANY FOOTPRINT
FIGURE 35
REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 36
EV/EBITDA OF KEY VENDORS
FIGURE 37
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 38
REMOTE PATIENT MONITORING MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
FIGURE 39
KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
FIGURE 40
OMRON CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 41
MEDTRONIC: COMPANY SNAPSHOT (2024)
FIGURE 42
GE HEALTHCARE: COMPANY SNAPSHOT (2025)
FIGURE 43
ABBOTT: COMPANY SNAPSHOT (2025)
FIGURE 44
ORACLE: COMPANY SNAPSHOT (2025)
FIGURE 45
BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 46
NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 47
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025)
FIGURE 48
BAXTER: COMPANY SNAPSHOT (2025)
FIGURE 49
TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2025)
FIGURE 50
RESEARCH DESIGN
FIGURE 51
PRIMARY SOURCES
FIGURE 52
INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 53
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 54
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 55
SUPPLY-SIDE MARKET ESTIMATION
FIGURE 56
REMOTE PATIENT MONITORING MARKET: REVENUE ESTIMATION APPROACH
FIGURE 57
BOTTOM-UP APPROACH: END USER SPENDING ON REMOTE PATIENT MONITORING
FIGURE 58
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2031)
FIGURE 59
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 60
TOP-DOWN APPROACH
FIGURE 61
DATA TRIANGULATION METHODOLOGY
Methodology
The study involved major activities in estimating the current market size for the remote patient monitoring market.
Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of the remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
BREAKDOWN OF PRIMARY INTERVIEW PARTICIPANTS
Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.
Market Definition
The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings, as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.
Key Stakeholders
- RPM Equipment and devices Manufacturers
- Suppliers and Distributors of RPM Equipment
- RPM software provider
- Healthcare IT Service Providers
- Healthcare Insurance Companies/Payers
- Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
- Venture Capitalists
- Government Bodies/Regulatory Bodies
- Corporate Entities
- Accountable Care Organizations
- RPM Resource Centers
- Research and Consulting Firms
- Medical Research Institutes
- Clinical Departments
Report Objectives
- To define, describe, and forecast the global remote patient monitoring market based on component, indication, end user, and region.
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall remote patient monitoring market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
- To strategically analyze the market structure profile of the key players of the remote patient monitoring market and comprehensively analyze their core competencies.
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
- To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, funding, grants, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the remote patient monitoring market during the forecast period.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
- Geographic Analysis: Further breakdown of Latin American remote patient monitoring into specific countries, the Middle East, and Africa remote patient monitoring into specific countries, and further breakdown of European remote patient monitoring into specific countries
Key Questions Addressed by the Report
The top market players in the global Remote patient monitoring include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Baxter (US), Biobeat (Israel), Biotronik (Germany), VitalConnect (US), VivaLNK, Inc (US), Clear Arch, Inc (US), Optum, Inc (Vivifyhealth) (US), Blue Spark Technologies, Inc (US), Lightbeam (US), Cloud Diagnostics Canada ULC (Canada), Teladoc Health, Inc (US), and Guangdong Transtek Medical Electronics Co., Ltd (China).
This report contains the following components:
-
Devices
-
By Function
- Cardiac monitoring devices
- Neurological monitoring devices
- Respiratory monitoring devices
- Blood glucose monitoring devices
- Fetal & neonatal monitoring devices
- Weight monitoring devices
- Multiparameter monitoring devices
- Pulse oximeter devices
- Thermometers
- Other monitoring devices (rehabilitation and physical therapy devices, fall detection devices, and others)
-
By Product type
- Wearable devices
- Implantable devices
- Handheld & portable devices
- Others (stationary devices, and others)
-
By Function
-
Software
-
By deployment model
- On-premise model
- Cloud-based model
-
By transmission type
- Synchronous
- Asynchronous
-
By deployment model
- Services
The global Remote patient monitoring is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America holds a substantial share, and the Asia Pacific is expected to register the highest growth rate during the forecast period.
The report contains the following industry segments:
-
Healthcare Providers
- Hospitals
- Ambulatory surgical centers, ambulatory care centers, and other outpatient settings
- Long-term care & assisted living facilities
- Home healthcare
- Other healthcare providers (diagnostics & imagining centers, rehabilitation centers, behavioural health centers, and others)
- Healthcare payers
- Patients
- Pharmaceutical & biotechnology companies
- MedTech companies
- Other end users (employer groups, government organizations, academic institutes, research centers, and others)
The market is expected to record a CAGR of 12.7% from 2024–2030.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Remote Patient Monitoring (RPM) Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Company
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Company
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnostics
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Previous Next
